172 related articles for article (PubMed ID: 10994546)
41. Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies.
Nie D; Zhang J; Wang F; Li X; Liu L; Zhang W; Cao P; Chen X; Zhang Y; Chen J; Ma X; Zhou X; Wu Q; Liu M; Liu M; Tian W; Liu H
Front Med; 2022 Jun; 16(3):459-466. PubMed ID: 34741701
[TBL] [Abstract][Full Text] [Related]
42. Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia.
Behera CK; Gyandeep G; Mishra R; Mohanty RP; Pal A; Behera J; Samal S; Das B
Mol Biol Rep; 2023 Jan; 50(1):931-936. PubMed ID: 36369330
[TBL] [Abstract][Full Text] [Related]
43. Incidence of malignancy and clonal chromosomal abnormalities in Fanconi anemia.
Vundinti BR; Korgaonkar S; Ghosh K
Indian J Cancer; 2010; 47(4):397-9. PubMed ID: 21131752
[TBL] [Abstract][Full Text] [Related]
44. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
45. Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co-occurring FANCC and CHEK2 mutations.
Berger G; van den Berg E; Smetsers S; Leegte BK; Sijmons RH; Abbott KM; Mulder AB; Vellenga E
Br J Haematol; 2019 Mar; 184(6):1071-1073. PubMed ID: 29767408
[No Abstract] [Full Text] [Related]
46. Novel Founder Mutation in
Dimishkovska M; Kotori VM; Gucev Z; Kocheva S; Polenakovic M; Plaseska-Karanfilska D
Balkan Med J; 2018 Jan; 35(1):108-111. PubMed ID: 29400309
[TBL] [Abstract][Full Text] [Related]
47. A case report of Fanconi anemia diagnosed by genetic testing followed by prenatal diagnosis.
Lee HJ; Park S; Kang HJ; Jun JK; Lee JA; Lee DS; Park SS; Seong MW
Ann Lab Med; 2012 Sep; 32(5):380-4. PubMed ID: 22950077
[TBL] [Abstract][Full Text] [Related]
48. Constitutional sequence variation in the Fanconi anaemia group C (FANCC) gene in childhood acute myeloid leukaemia.
Barber LM; McGrath HE; Meyer S; Will AM; Birch JM; Eden OB; Taylor GM
Br J Haematol; 2003 Apr; 121(1):57-62. PubMed ID: 12670332
[TBL] [Abstract][Full Text] [Related]
49. [Hereditary diseases with propensity to myeloid malignancy].
Yagasaki H; Mugishima H
Nihon Rinsho; 2009 Oct; 67(10):1884-8. PubMed ID: 19860184
[TBL] [Abstract][Full Text] [Related]
50. Acute myeloid leukemia arising to genetic susceptibility genes related T cell acute lymphoblastic leukemia: case report.
Guo Y; Liao X; Zou P; Xiao J
AME Case Rep; 2021; 5():29. PubMed ID: 34312608
[TBL] [Abstract][Full Text] [Related]
51. Screening for mutations in two exons of FANCG gene in Pakistani population.
Aymun U; Iram S; Aftab I; Khaliq S; Nadir A; Nisar A; Mohsin S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):158-163. PubMed ID: 28627524
[TBL] [Abstract][Full Text] [Related]
52. Fanconi anaemia in black South African patients heterozygous for the FANCG c.637-643delTACCGCC founder mutation.
Wainstein T; Kerr R; Mitchell CL; Madaree S; Essop FB; Vorster E; Wainwright R; Poole J; Krause A
S Afr Med J; 2013 Oct; 103(12 Suppl 1):970-3. PubMed ID: 24300640
[TBL] [Abstract][Full Text] [Related]
53. Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family.
Solyom S; Winqvist R; Nikkilä J; Rapakko K; Hirvikoski P; Kokkonen H; Pylkäs K
Cancer Lett; 2011 Mar; 302(2):113-8. PubMed ID: 21236561
[TBL] [Abstract][Full Text] [Related]
54. FANCC Dutch founder mutation in a Mennonite family from Tamaulipas, México.
García-de Teresa B; Frias S; Molina B; Villarreal MT; Rodriguez A; Carnevale A; López-Hernández G; Vollbrechtshausen L; Olaya-Vargas A; Torres L
Mol Genet Genomic Med; 2019 Jun; 7(6):e710. PubMed ID: 31044565
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia.
Condie A; Powles RL; Hudson CD; Shepherd V; Bevan S; Yuille MR; Houlston RS
Leuk Lymphoma; 2002 Sep; 43(9):1849-53. PubMed ID: 12685843
[TBL] [Abstract][Full Text] [Related]
56. Mutation analysis of the WT1 gene in myelodysplastic syndromes.
Hosoya N; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Jpn J Cancer Res; 1998 Aug; 89(8):821-4. PubMed ID: 9765617
[TBL] [Abstract][Full Text] [Related]
57. Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients.
Mori M; Hira A; Yoshida K; Muramatsu H; Okuno Y; Shiraishi Y; Anmae M; Yasuda J; Tadaka S; Kinoshita K; Osumi T; Noguchi Y; Adachi S; Kobayashi R; Kawabata H; Imai K; Morio T; Tamura K; Takaori-Kondo A; Yamamoto M; Miyano S; Kojima S; Ito E; Ogawa S; Matsuo K; Yabe H; Yabe M; Takata M
Haematologica; 2019 Oct; 104(10):1962-1973. PubMed ID: 30792206
[TBL] [Abstract][Full Text] [Related]
58. A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing.
Solomon PJ; Margaret P; Rajendran R; Ramalingam R; Menezes GA; Shirley AS; Lee SJ; Seong MW; Park SS; Seol D; Seo SH
Ital J Pediatr; 2015 May; 41():38. PubMed ID: 25953249
[TBL] [Abstract][Full Text] [Related]
59. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.
Lensch MW; Rathbun RK; Olson SB; Jones GR; Bagby GC
Leukemia; 1999 Nov; 13(11):1784-9. PubMed ID: 10557053
[TBL] [Abstract][Full Text] [Related]
60. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
